Controlled Release Drug Delivery Market By Technology (Targeted Delivery, Transdermal, Implants, Microencapsulation, Coacervation, Wurster Technique, and Others), By Release Mechanism (Activation-Modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems, and Polymer-Based Systems), By Application (Drug-Eluting Stents, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Injectable, Transdermal & Ocular Patches, and Metered Dose Inhalers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 23-Feb-2021 Category: Chemical & Materials Report Format : PDF Pages: 110 Report Code: ZMR-5835 Status : Published

The controlled release drug delivery market is set for a rapid growth over the forecast period. In terms of revenue, the global automated sortation system market accounted for USD 36.49 Billion in 2019 and is expected to reach USD 59.36 Billion by 2026, growing at a CAGR of 7.4% from 2020 to 2026.

Description

The controlled release drug delivery market is set for a rapid growth over the forecast period. In terms of revenue, the global automated sortation system market accounted for USD 36.49 Billion in 2019 and is expected to reach USD 59.36 Billion by 2026, growing at a CAGR of 7.4% from 2020 to 2026.

Global Controlled Release Drug Delivery Market: Overview

Controlled release drug delivery is a dosage form that delivers medication in a predetermined way. It is a mechanism that facilitates continuous drug delivery in reproducible kinetics for a fixed time throughout the gastrointestinal transit course. It keeps on releasing the drug dosages until it reaches the predetermined region in the gastrointestinal tract. There are several benefits of such a drug delivery system like higher bioavailability, enhanced patient compliance, efficacy, improved drug safety, minimum side effects, lower dose requirement, and improved stability of the drug.

Global Controlled Release Drug Delivery Market: Growth Factors

The growing preference of the medical professionals for the controlled-release drug coupled with the changing prescription patterns over traditional drug delivery systems is driving the growth of the global controlled release drug delivery market significantly. Moreover, being a highly fragmented and competitive market, the major market players are pro-active with the transforming requirements and are increasingly investing in innovating and developing more advanced drugs to drive the global controlled release drug delivery market vigorously. The growing research and development activities to develop efficient therapy for non-communicable and chronic diseases like hypertension, diabetes, and cancer are fueling the growth of the market globally. The constantly growing pediatric and geriatric population is boosting the market growth significantly owing to the non-adherence to the medical routine. The geriatric population suffers from the biological, mental, and physical malfunction that affects medical intake. Their body is not able to tolerate the optimum dosages and ill effects of drugs and hence it fuels the demand for the controllable release drug delivery system.

Global Controlled Release Drug Delivery Market: Segmentation

The global controlled release drug delivery market can be segmented into technology, application, release mechanism outlook, and region.

By technology, the market can be segmented into targeted delivery, transdermal, implants, microencapsulation, coacervation, Wurster technique, and others. The targeted delivery accounts for the largest share in the global controlled release drug delivery market due to its added advantages like it aids in permitting drugs to stay away from the area or region that might cause drug toxicity and facilities required site of action.

By release mechanism outlook, the market can be segmented into activation-modulated drug delivery systems, micro reservoir partition controlled drug delivery systems, chemically activated, feedback regulated drug delivery systems, and polymer-based systems. The feedback-regulated drug delivery systems segment dominates the global market due to their high therapeutic efficiency in treating various diseases.

By application, the market can be segmented into drug-eluting stents, infusion pumps, oral controlled-drug delivery systems, injectable, transdermal & ocular patches, and metered dose inhalers. The oral controlled-drug delivery systems hold hegemony over others owing to their frequent uses and wide availability.

Global Controlled Release Drug Delivery Market: Regional analysis

North America accounts for the largest share in the global controlled release drug delivery market owing to the growing supportive initiatives from the government for the developments of the regional market. Moreover, the surging research and development activities are anticipated to propel the regional market growth.

Europe is expected to witness huge growth due to the presence of prominent market players in the region coupled with the increasing incidences of patients suffering from chronic illnesses like diabetes, cancer, chronic obstructive pulmonary disease (COPD), and many others.

Asia Pacific is a potential region in the global controlled release drug delivery market and is likely to grow significantly during the forecast period owing to the growing development of healthcare infrastructure and surging geriatric population in the region.

Global Controlled Release Drug Delivery Market: Competitive Players

Some of the major players in the global controlled release drug delivery market are APOLLO RT Co. Ltd., Sino Medical-Device Technology Co., Ltd., VIVID IMAGING, GE Healthcare, Nemoto Kyorindo Co., Ltd., Ulrich GmbH & Co. KG, Bayer HealthCare LLC, Medtronic AG, Guerbet Group, Bracco Group, Capsugel, Aradigm Corporation, Pfizer, Inc, Depomed, Inc., Corium International, Inc., Coating Place, Inc., Johnson and Johnson, Alkermes plc, Merck and Co., Inc., F. Hoffman-La-Roche Ltd., Sanofi, Mylan N.V., GlaxoSmithKline plc, Vectura Group plc, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Bristol-Myers Squibb Company, and Orbis Biosciences, Inc., among others.

The global controlled release drug delivery market is segmented as follows:

By Technology

  • Targeted Delivery
  • Transdermal
  • Implants
  • Micro Encapsulation
  • Coacervation
  • Wurster Technique
  • Others

By Release Mechanism

  • Activation-modulated Drug Delivery Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Chemically Activated
  • Feedback Regulated Drug Delivery Systems
  • Polymer-Based Systems

By Application

  • Drug Eluting Stents
  • Infusion Pumps
  • Oral Controlled-Drug Delivery Systems
  • Injectable
  • Transdermal and Ocular Patches
  • Metered Dose Inhalers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.1.Report Scope
  • Chapter 2.Research Methodulogy
    • 2.1.Research Methodulogy
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Contrulled Release Drug Delivery Market, 2016 – 2026 (USD Million)
    • 3.2.Global Contrulled Release Drug Delivery Market: Snapshot
  • Chapter 4.Contrulled Release Drug Delivery Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
    • 4.3.Market Restraints
    • 4.4.Market Opportunities
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Contrulled Release Drug Delivery Market Attractiveness, By Technulogy
    • 5.2.Global Contrulled Release Drug Delivery Market Attractiveness, By Release Mechanism
    • 5.3.Global Contrulled Release Drug Delivery Market Attractiveness, By Application
    • 5.4.Global Contrulled Release Drug Delivery Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Contrulled Release Drug Delivery Market: Company Market Share, 2019
    • 6.2.Strategic Developments
    • 7.1.Global Contrulled Release Drug Delivery Market Overview: by Technulogy
      • 7.1.1.Global Contrulled Release Drug Delivery Market Revenue Share, by Technulogy, 2019 & 2026
    • 7.2.Global Contrulled Release Drug Delivery Market Analysis/Overview – By Technulogy
      • 7.2.1.Targeted Delivery – Overview/Analysis
      • 7.2.2.Transdermal – Overview/Analysis
      • 7.2.3.Implants – Overview/Analysis
      • 7.2.4.Micro Encapsulation – Overview/Analysis
      • 7.2.5.Coacervation – Overview/Analysis
      • 7.2.6.Wurster Technique – Overview/Analysis
      • 7.2.7.Others – Overview/Analysis
    • 7.3.Targeted Delivery
      • 7.3.1.Global Contrulled Release Drug Delivery Market for Targeted Delivery, Revenue (USD Million) 2016 - 2026
    • 7.4.Transdermal
      • 7.4.1.Global Contrulled Release Drug Delivery Market for Transdermal, Revenue (USD Million) 2016 - 2026
    • 7.5.Implants
      • 7.5.1.Global Contrulled Release Drug Delivery Market for Implants, Revenue (USD Million) 2016 - 2026
    • 7.6.Micro Encapsulation
      • 7.6.1.Global Contrulled Release Drug Delivery Market for Micro Encapsulation, Revenue (USD Million) 2016 - 2026
    • 7.7.Coacervation
      • 7.7.1.Global Contrulled Release Drug Delivery Market for Coacervation, Revenue (USD Million) 2016 - 2026
    • 7.8.Wurster Technique
      • 7.8.1.Global Contrulled Release Drug Delivery Market for Wurster Technique, Revenue (USD Million) 2016 - 2026
    • 7.9.Others
      • 7.9.1.Global Contrulled Release Drug Delivery Market for Others, Revenue (USD Million) 2016 - 2026
    • 8.1.Global Contrulled Release Drug Delivery Market Overview: by Release Mechanism
      • 8.1.1.Global Contrulled Release Drug Delivery Market Revenue Share, by Release Mechanism, 2019 & 2026
    • 8.2.Global Contrulled Release Drug Delivery Market Analysis/Overview – By Release Mechanism
      • 8.2.1.Activation-Modulated Drug Delivery Systems – Overview/Analysis
      • 8.2.2.Micro Reservoir Partition Contrulled Drug Delivery Systems – Overview/Analysis
      • 8.2.3.Chemically Activated – Overview/Analysis
      • 8.2.4.Feedback Regulated Drug Delivery Systems – Overview/Analysis
      • 8.2.5.Pulymer-Based Systems – Overview/Analysis
    • 8.3.Activation-Modulated Drug Delivery Systems
      • 8.3.1.Global Contrulled Release Drug Delivery Market for Activation-Modulated Drug Delivery Systems, Revenue (USD Million) 2016 - 2026
    • 8.4.Micro Reservoir Partition Contrulled Drug Delivery Systems
      • 8.4.1.Global Contrulled Release Drug Delivery Market for Micro Reservoir Partition Contrulled Drug Delivery Systems, Revenue (USD Million) 2016 - 2026
    • 8.5.Chemically Activated
      • 8.5.1.Global Contrulled Release Drug Delivery Market for Chemically Activated, Revenue (USD Million) 2016 - 2026
    • 8.6.Feedback Regulated Drug Delivery Systems
      • 8.6.1.Global Contrulled Release Drug Delivery Market for Feedback Regulated Drug Delivery Systems, Revenue (USD Million) 2016 - 2026
    • 8.7.Pulymer-Based Systems
      • 8.7.1.Global Contrulled Release Drug Delivery Market for Pulymer-Based Systems, Revenue (USD Million) 2016 - 2026
    • 9.1.Global Contrulled Release Drug Delivery Market Overview: by Application
      • 9.1.1.Global Contrulled Release Drug Delivery Market Revenue Share, by Application, 2019 & 2026
    • 9.2.Global Contrulled Release Drug Delivery Market Analysis/Overview – By Application
      • 9.2.1.Drug Eluting Stents – Overview/Analysis
      • 9.2.2.Infusion Pumps – Overview/Analysis
      • 9.2.3.Oral Contrulled-Drug Delivery Systems – Overview/Analysis
      • 9.2.4.Injectable – Overview/Analysis
      • 9.2.5.Transdermal and Ocular Patches – Overview/Analysis
      • 9.2.6.Metered Dose Inhalers – Overview/Analysis
    • 9.3.Drug Eluting Stents
      • 9.3.1.Global Contrulled Release Drug Delivery Market for Drug Eluting Stents, Revenue (USD Million) 2016 - 2026
    • 9.4.Infusion Pumps
      • 9.4.1.Global Contrulled Release Drug Delivery Market for Infusion Pumps, Revenue (USD Million) 2016 - 2026
    • 9.5.Oral Contrulled-Drug Delivery Systems
      • 9.5.1.Global Contrulled Release Drug Delivery Market for Oral Contrulled-Drug Delivery Systems, Revenue (USD Million) 2016 - 2026
    • 9.6.Injectable
      • 9.6.1.Global Contrulled Release Drug Delivery Market for Injectable, Revenue (USD Million) 2016 - 2026
    • 9.7.Transdermal and Ocular Patches
      • 9.7.1.Global Contrulled Release Drug Delivery Market for Transdermal and Ocular Patches, Revenue (USD Million) 2016 - 2026
    • 9.8.Metered Dose Inhalers
      • 9.8.1.Global Contrulled Release Drug Delivery Market for Metered Dose Inhalers, Revenue (USD Million) 2016 - 2026
  • Chapter 10.Contrulled Release Drug Delivery Market – Regional Analysis
    • 10.1.Global Contrulled Release Drug Delivery Market: Regional Overview
      • 10.1.1.Global Contrulled Release Drug Delivery Market Revenue Share, by Region, 2019 & 2026
      • 10.1.2.Global Contrulled Release Drug Delivery Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 10.2.North America
      • 10.2.1.North America Contrulled Release Drug Delivery Market Revenue, 2016 - 2026 (USD Million)
      • 10.2.2.North America Contrulled Release Drug Delivery Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.2.3.North America Contrulled Release Drug Delivery Market Revenue, by Technulogy, 2016 – 2026
      • 10.2.4.North America Contrulled Release Drug Delivery Market Revenue, by Release Mechanism, 2016 – 2026
      • 10.2.5.North America Contrulled Release Drug Delivery Market Revenue, by Application, 2016 – 2026
      • 10.2.6. U.S.
      • 10.2.7.Canada
    • 10.3.Europe
      • 10.3.1.Europe Contrulled Release Drug Delivery Market Revenue, 2016 - 2026 (USD Million)
      • 10.3.2.Europe Contrulled Release Drug Delivery Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.3.3.Europe Contrulled Release Drug Delivery Market Revenue, by Technulogy, 2016 – 2026
      • 10.3.4.Europe Contrulled Release Drug Delivery Market Revenue, by Release Mechanism, 2016 – 2026
      • 10.3.5.Europe Contrulled Release Drug Delivery Market Revenue, by Application, 2016 – 2026
      • 10.3.6.Germany
      • 10.3.7.France
      • 10.3.8. U.K.
      • 10.3.9.Italy
      • 10.3.10.Spain
      • 10.3.11.Rest of Europe
    • 10.4.Asia Pacific
      • 10.4.1.Asia Pacific Contrulled Release Drug Delivery Market Revenue, 2016 - 2026 (USD Million)
      • 10.4.2.Asia Pacific Contrulled Release Drug Delivery Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.4.3.Asia Pacific Contrulled Release Drug Delivery Market Revenue, by Technulogy, 2016 – 2026
      • 10.4.4.Asia Pacific Contrulled Release Drug Delivery Market Revenue, by Release Mechanism, 2016 – 2026
      • 10.4.5.Asia Pacific Contrulled Release Drug Delivery Market Revenue, by Application, 2016 – 2026
      • 10.4.6.China
      • 10.4.7.Japan
      • 10.4.8.India
      • 10.4.9.South Korea
      • 10.4.10.South-East Asia
      • 10.4.11.Rest of Asia Pacific
    • 10.5.Latin America
      • 10.5.1.Latin America Contrulled Release Drug Delivery Market Revenue, 2016 - 2026 (USD Million)
      • 10.5.2.Latin America Contrulled Release Drug Delivery Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.5.3.Latin America Contrulled Release Drug Delivery Market Revenue, by Technulogy, 2016 – 2026
      • 10.5.4.Latin America Contrulled Release Drug Delivery Market Revenue, by Release Mechanism, 2016 – 2026
      • 10.5.5.Latin America Contrulled Release Drug Delivery Market Revenue, by Application, 2016 – 2026
      • 10.5.6.Brazil
      • 10.5.7.Mexico
      • 10.5.8.Rest of Latin America
    • 10.6.The Middle-East and Africa
      • 10.6.1.The Middle-East and Africa Contrulled Release Drug Delivery Market Revenue, 2016 - 2026 (USD Million)
      • 10.6.2.The Middle-East and Africa Contrulled Release Drug Delivery Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.6.3.The Middle-East and Africa Contrulled Release Drug Delivery Market Revenue, by Technulogy, 2016 – 2026
      • 10.6.4.The Middle-East and Africa Contrulled Release Drug Delivery Market Revenue, by Release Mechanism, 2016 – 2026
      • 10.6.5.The Middle-East and Africa Contrulled Release Drug Delivery Market Revenue, by Application, 2016 – 2026
      • 10.6.6.GCC Countries
      • 10.6.7.South Africa
      • 10.6.8.Rest of Middle-East Africa
  • Chapter 11.Company Profiles
    • 11.1.APOLLO RT Co. Ltd.
      • 11.1.1.Company Overview
      • 11.1.2.Financial Overview
      • 11.1.3.Product Portfulio
      • 11.1.4.Business Strategy
      • 11.1.5.Recent Developments
    • 11.2.Sino Medical-Device Technulogy Co., Ltd.
    • 11.3.VIVID IMAGING
    • 11.4.GE Healthcare
    • 11.5.Nemoto Kyorindo Co., Ltd.
    • 11.6.Ulrich GmbH & Co. KG
    • 11.7.Bayer HealthCare LLC
    • 11.8.Medtronic AG
    • 11.9.Guerbet Group
    • 11.1.Bracco Group
    • 11.11.Capsugel
    • 11.12.Aradigm Corporation
    • 11.13.Pfizer, Inc.
    • 11.14.Depomed, Inc.
    • 11.15.Corium International, Inc.
    • 11.16.Coating Place, Inc.
    • 11.17.Johnson and Johnson
    • 11.18.Alkermes plc
    • 11.19.Merck and Co., Inc.
    • 11.2.F. Hoffman-La-Roche Ltd.
    • 11.21.Sanofi
    • 11.22.Mylan N.V.
    • 11.23.GlaxoSmithKline plc
    • 11.24.Vectura Group plc
    • 11.25.Sun Pharmaceuticals Industries Ltd.
    • 11.26.Abbott Laboratories
    • 11.27.Bristul-Myers Squibb Company
    • 11.28.Orbis Biosciences, Inc.

Methodology


Frequently Asked Questions

The global controlled release drug delivery market was valued at USD 36.49 Billion in 2019.

The global controlled release drug delivery market is expected to reach USD 59.36 Million by 2026, growing at a CAGR of 7.4% between 2020 to 2026.

The growing preference of the medical professionals for the controlled-release drug coupled with the changing prescription patterns over traditional drug delivery systems is driving the growth of the global controlled release drug delivery market significantly. Moreover, being a highly fragmented and competitive market, the major market players are pro-active with the transforming requirements and are increasingly investing in innovating and developing more advanced drugs to drive the global controlled release drug delivery market vigorously.

North America accounts for the largest share in the global controlled release drug delivery market owing to the growing supportive initiatives from the government for the developments of the regional market. Moreover, the surging research and development activities are anticipated to propel the regional market growth.

Some of the major companies operating in the controlled release drug delivery market are APOLLO RT Co. Ltd., Sino Medical-Device Technology Co., Ltd., VIVID IMAGING, GE Healthcare, Nemoto Kyorindo Co., Ltd., Ulrich GmbH & Co. KG, Bayer HealthCare LLC, Medtronic AG, Guerbet Group, Bracco Group, Capsugel, Aradigm Corporation, Pfizer, Inc, Depomed, Inc., among others.
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social